Agilent Technologies (A) Total Non-Current Liabilities (2009 - 2026)
Agilent Technologies' (A) quarterly Total Non-Current Liabilities came in at $6.1 billion in Q3 2026, up 13.08% year-over-year from $5.4 billion in Q3 2025, and up 11.29% quarter-over-quarter from $5.4 billion in Q2 2026.
Analysis
Agilent Technologies (A) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Agilent Technologies (A) has reported Total Non-Current Liabilities for 18 consecutive years, with $6.1 billion the latest figure, recorded in Q3 2026.
- On a quarterly basis, Total Non-Current Liabilities rose 13.08% year-over-year to $6.1 billion in Q3 2026; TTM through Jul 2026 was $6.1 billion, a 13.08% increase from a year earlier, with the FY2025 full-year figure at $5.5 billion, up 2.85% from the prior year.
- Total Non-Current Liabilities was $6.1 billion for Q3 2026 at Agilent Technologies, up from $5.4 billion in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $6.1 billion in Q3 2026 and troughed at $4.4 billion in Q4 2023.
- A 5-year average of $5.2 billion and a median of $5.3 billion in 2023 frame the typical range for Total Non-Current Liabilities.
- Across the five-year window, Total Non-Current Liabilities retreated 13.93% in 2023 and rose 20.92% in 2024, its largest moves.
- Over 5 years, Total Non-Current Liabilities stood at $5.2 billion in 2022, then dropped by 13.93% to $4.4 billion in 2023, then rose by 20.92% to $5.4 billion in 2024, then gained by 2.85% to $5.5 billion in 2025, then increased by 9.76% to $6.1 billion in 2026.
- The last three Total Non-Current Liabilities figures came in at $6.1 billion (Q3 2026), $5.4 billion (Q2 2026), and $5.4 billion (Q1 2026), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 55.95 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 33.25 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 6.06 Bn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 3.52 Bn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 4.05 Bn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 457.16 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 2.88 Bn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 821.06 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 197.96 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 3.06 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 6.06 Bn |
| Apr 30, 2026 | 5.45 Bn |
| Jan 31, 2026 | 5.41 Bn |
| Oct 31, 2025 | 5.52 Bn |
| Jul 31, 2025 | 5.36 Bn |
| Apr 30, 2025 | 5.49 Bn |
| Jan 31, 2025 | 5.34 Bn |
| Oct 31, 2024 | 5.37 Bn |
| Jul 31, 2024 | 4.62 Bn |
| Apr 30, 2024 | 4.64 Bn |
| Jan 31, 2024 | 4.76 Bn |
| Oct 31, 2023 | 4.44 Bn |
| Jul 31, 2023 | 5.11 Bn |
| Apr 30, 2023 | 5.00 Bn |
| Jan 31, 2023 | 5.31 Bn |
| Oct 31, 2022 | 5.16 Bn |
| Jul 31, 2022 | 5.33 Bn |
| Apr 30, 2022 | 5.27 Bn |
| Jan 31, 2022 | 5.08 Bn |
| Oct 31, 2021 | 5.23 Bn |